All Studies

Aromatic glycosides and lignans glycosides with their acetylcholinesterase inhibitory activities from the leaves of Picrasma quassioides.

In this study, researchers isolated eight new natural products from Picrasma quassioides leaves. They determined their structures and found that compound 6 showed weak inhibitory activity against acetylcholinesterase, which could be relevant for Alzheimer's disease. Molecular docking illustrated the interaction between compound 6 and AChE active sites.

Jia Q et al (2023).
Fitoterapia.
PubMed:
37832877

Evaluation of the anti-inflammatory and antioxidant properties, and the isolation and characterization of a new bioactive compound, 3,4,9-trimethyl-7-propyldecanoic acid, from Vitex negundo.

Sivapalan S et al (2023).
J Ethnopharmacol.
PubMed:
37832812

Using ultra-performance liquid chromatography with linear ion trap-electrostatic field orbitrap mass spectrometry, network pharmacology, and molecular docking to explore the constituent targets and action mechanisms of decoction of Angelica sinensis, Zingiberis Rhizoma Recens, and Mutton in the treatment of diarrhea-predominant irritable bowel syndrome.

Liu Z et al (2023).
J Pharm Pharmacol.
PubMed:
37832514

Antiviral, virucidal and antioxidant properties of Artemisia annua against SARS-CoV-2.

The study found that extracts from Artemisia annua (sweet wormwood) have virucidal, antiviral, and antioxidant effects against COVID-19. Specific compounds from the plant show potential in inhibiting viral replication. Therefore, A. annua could be useful in fighting SARS-CoV-2 variants and future coronaviruses.

Baggieri M et al (2023).
Biomed Pharmacother.
PubMed:
37832410